EU Eosinophilic Esophagitis Market, Market Segmented by Diagnosis (Upper Endoscopy, Esophagus Biopsy, Blood Tests, Others), by Treatment (Dietary therapy, Medication, Dilation, Others), by Route of Administration (Dietary therapy, Medication, Dilation, Others), and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) - Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138295
- Pages: 200
-
Format:
Report Overview
The EU Eosinophilic Esophagitis Market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period
Eosinophilic esophagitis (EoE) is the chronic immune system condition in which a type of white blood cells called eosinophil accumulates in the lining of esophagus. This accumulation of eosinophil due to some food & allergens reaction or acid reflux causes inflammation or severe damage to the esophagus. Damaged esophagus tissue of esophagus can cause difficulty in swallowing, drinking and food stuck in the tract
Market Drivers
Growing cases of digestive tract inflammatory diseases drives the eosinophilic esophagitis (EoE) market. Due to the increased allergy in esophagus, accumulation of eosinophils, dysphagia & impaction in esophagus also boost up the eosinophilic esophagitis (EoE) market growth. Furthermore, lack of diseases awareness, acceptance of the treatment for specific region is difficult which may hamper the global eosinophilic esophagitis (EoE) market
1. EU Eosinophilic Esophagitis Market Overview
A. Market Size
2. EU Eosinophilic Esophagitis Market Growth Drivers and Restraints.
A. Growing cases of digestive tract inflammatory diseases
B. Due to the increased allergy in esophagus, accumulation of eosinophils, dysphagia & impaction in esophagus
C. Lack of diseases awareness
3. EU Eosinophilic Esophagitis Market Segmentation
A. By Diagnosis
I. Upper Endoscopy
II. Esophagus Biopsy
III. Blood Tests
IV. Others
B. By Treatment
I. Dietary therapy
II. Medications
III. Dilation
IV. Others
C. By Route of Administration
I. Oral
II. Parental
III. Others
D. By End-Users
I. Hospitals
II. Speciality Clinics
III. Others
4. EU Eosinophilic Esophagitis Major Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Glaxo Smith Kline, Company overview, Product & Services, Strategies & Financials
B. Mylan N.V, Company overview, Product & Services, Strategies & Financials
C. Astra Zeneca, Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
